| 1 | closely | 3,136 |
| 2 | linearly | 833 |
| 3 | strictly | 611 |
| 4 | tightly | 387 |
| 5 | temporally | 254 |
| 6 | causally | 202 |
| 7 | finely | 93 |
| 8 | quadratically | 76 |
| 9 | intimately | 75 |
| 10 | loosely | 67 |
| 11 | monotonically | 55 |
| 12 | narrowly | 48 |
| 13 | distantly | 47 |
| 14 | inextricably | 28 |
| 15 | intricately | 25 |
| 16 | menstrually | 25 |
| 17 | nonlinearly | 24 |
| 18 | reversely | 21 |
| 19 | integrally | 17 |
| 20 | non-linearly | 17 |
| 21 | curvilinearly | 16 |
| 22 | clonally | 12 |
| 23 | pathogenically | 9 |
| 24 | centrosymmetrically | 7 |
| 25 | rad3 | 6 |
| 26 | unidirectionally | 6 |
| 27 | antiferromagnetically | 5 |
| 28 | compactly | 5 |
| 29 | interior-exteriorly | 5 |
| 30 | multiplicatively | 5 |
| 31 | delicately | 4 |
| 32 | ferromagnetically | 4 |
| 33 | bronchorrhoea | 3 |
| 34 | c44 | 3 |
| 35 | causatively | 3 |
| 36 | dsylipidemia | 3 |
| 37 | hyperbolically | 3 |
| 38 | non-bp | 3 |
| 39 | non-conflict | 3 |
| 40 | non-dmard | 3 |
| 41 | non-enzymatically | 3 |
| 42 | a-1000 | 2 |
| 43 | calcitonin-gene | 2 |
| 44 | coitally | 2 |
| 45 | critera | 2 |
| 46 | exterior-interiorly | 2 |
| 47 | gm1-enzyme | 2 |
| 48 | most-strongly | 2 |
| 49 | non-biologically | 2 |
| 50 | propkhmgr-d2 | 2 |
| 51 | study-treatment | 2 |
| 52 | symbiotically | 2 |
| 53 | wuschel | 2 |
| 54 | ''topologically | 1 |
| 55 | -1.06mj/kg | 1 |
| 56 | -140.62 | 1 |
| 57 | -172.08 | 1 |
| 58 | -177.7 | 1 |
| 59 | -178.24 | 1 |
| 60 | -2.4±0.1 | 1 |
| 61 | -pyrimidine-4-one | 1 |
| 62 | .alcohol | 1 |
| 63 | .asthma | 1 |
| 64 | 0.0045ngmg | 1 |
| 65 | 0.045‰ | 1 |
| 66 | 0.082±0.004 | 1 |
| 67 | 0.14×10 | 1 |
| 68 | 0.64f | 1 |
| 69 | 1.04×10 | 1 |
| 70 | 1.28±2.12 | 1 |
| 71 | 1.71×10 | 1 |
| 72 | 1.97×10 | 1 |
| 73 | 10,379pounds | 1 |
| 74 | 1006.7nmol·l | 1 |
| 75 | 105cm | 1 |
| 76 | 108.40 | 1 |
| 77 | 11,428pounds | 1 |
| 78 | 112,883 | 1 |
| 79 | 116.04 | 1 |
| 80 | 125/50 | 1 |
| 81 | 127,760 | 1 |
| 82 | 13500w | 1 |
| 83 | 15.8×10 | 1 |
| 84 | 192iridium | 1 |
| 85 | 2.038 | 1 |
| 86 | 2.7x10 | 1 |
| 87 | 2.82×10 | 1 |
| 88 | 2.9x10 | 1 |
| 89 | 2007-004840-60 | 1 |
| 90 | 2020vp1 | 1 |
| 91 | 23.22±0.7m | 1 |
| 92 | 299.89ngkg | 1 |
| 93 | 2α-hydroxyl-3β-angeloylcinnamolide | 1 |
| 94 | 3-nitrobenzonitrile | 1 |
| 95 | 3.370 | 1 |
| 96 | 3.4051 | 1 |
| 97 | 3.56×10 | 1 |
| 98 | 3.8x10 | 1 |
| 99 | 36.5μmol·l | 1 |
| 100 | 4.36×10 | 1 |
| 101 | 4.69×10 | 1 |
| 102 | 4773 | 1 |
| 103 | 5.1162 | 1 |
| 104 | 5.176 | 1 |
| 105 | 5.2gy | 1 |
| 106 | 50-59years | 1 |
| 107 | 51.70 | 1 |
| 108 | 57.52×10 | 1 |
| 109 | 6,143 | 1 |
| 110 | 6.677 | 1 |
| 111 | 6.6x10 | 1 |
| 112 | 60/60/60 | 1 |
| 113 | 65.59 | 1 |
| 114 | 7.028 | 1 |
| 115 | 77.29 | 1 |
| 116 | 78.24 | 1 |
| 117 | 8-symptom | 1 |
| 118 | 8.13×10 | 1 |
| 119 | 80.96 | 1 |
| 120 | 81.33 | 1 |
| 121 | 82.47 | 1 |
| 122 | 85.31 | 1 |
| 123 | 87.37 | 1 |
| 124 | 87.41 | 1 |
| 125 | 87.62 | 1 |
| 126 | 88.48 | 1 |
| 127 | 9.11×10 | 1 |
| 128 | 9.3gy | 1 |
| 129 | action-scripts | 1 |
| 130 | air-bronchiologram | 1 |
| 131 | baroceptor | 1 |
| 132 | bi-univocally | 1 |
| 133 | bv-were | 1 |
| 134 | chictr-trc-11001480 | 1 |
| 135 | circadian-rhythm | 1 |
| 136 | co-coverage | 1 |
| 137 | communitaire | 1 |
| 138 | connected/very | 1 |
| 139 | crumpled | 1 |
| 140 | cvd- | 1 |
| 141 | determined.issys | 1 |
| 142 | determined.variables | 1 |
| 143 | digestion-absorption | 1 |
| 144 | dollars12.2 | 1 |
| 145 | dollars37 | 1 |
| 146 | dollars406 | 1 |
| 147 | don-resistance | 1 |
| 148 | dosexdifficulty | 1 |
| 149 | dysmenorrheal-relieving | 1 |
| 150 | employed/occupied | 1 |
| 151 | endohedrally | 1 |
| 152 | entropion/trichiasis | 1 |
| 153 | enzym | 1 |
| 154 | epidemiologicaly | 1 |
| 155 | fluidically | 1 |
| 156 | gerd-health | 1 |
| 157 | ggaactn | 1 |
| 158 | ghrelin/ghrh | 1 |
| 159 | gse38942 | 1 |
| 160 | haart- | 1 |
| 161 | hemivaginas | 1 |
| 162 | hfe- | 1 |
| 163 | hypkalemia | 1 |
| 164 | index-aigr | 1 |
| 165 | inexpressive | 1 |
| 166 | invetory | 1 |
| 167 | k=2×10 | 1 |
| 168 | li1.04ni | 1 |
| 169 | lv-fibrosis | 1 |
| 170 | manoeuvrable | 1 |
| 171 | monflorite-huesca | 1 |
| 172 | monotropically | 1 |
| 173 | myo-inosiol | 1 |
| 174 | n-c3 | 1 |
| 175 | n-vanillyl-hexadecanamide | 1 |
| 176 | nct00473837 | 1 |
| 177 | nitratable | 1 |
| 178 | nkrp1c | 1 |
| 179 | non-avm | 1 |
| 180 | non-breed | 1 |
| 181 | non-childbirth | 1 |
| 182 | non-determinant | 1 |
| 183 | non-epilepsy | 1 |
| 184 | non-larynx | 1 |
| 185 | non-proportionally | 1 |
| 186 | nonlinear-linear-nonlinear | 1 |
| 187 | nonmenstrually | 1 |
| 188 | nonsuperimposable | 1 |
| 189 | p-distance=0.007/0.068 | 1 |
| 190 | pad-symptoms | 1 |
| 191 | poly-phenols | 1 |
| 192 | polyglutamine-disease | 1 |
| 193 | possession-cult | 1 |
| 194 | possibly/probably | 1 |
| 195 | pound209 | 1 |
| 196 | pound82 | 1 |
| 197 | pseudocentrosymmetrically | 1 |
| 198 | quercetin-3-rutinoside | 1 |
| 199 | raek^ | 1 |
| 200 | recordedand | 1 |
| 201 | restabilized | 1 |
| 202 | restriction-site | 1 |
| 203 | rhc-dha | 1 |
| 204 | rm1,664.46 | 1 |
| 205 | rm1,978.00 | 1 |
| 206 | rps2 | 1 |
| 207 | s-2- | 1 |
| 208 | stigma- | 1 |
| 209 | subnets | 1 |
| 210 | tag-snp | 1 |
| 211 | telediagnosis | 1 |
| 212 | thermocompression | 1 |
| 213 | thioredoxin-deficient | 1 |
| 214 | timed-artificially | 1 |
| 215 | traits-those | 1 |
| 216 | trimethoprim-sulfamethoxaxole | 1 |
| 217 | ubt-positive | 1 |
| 218 | wm-load | 1 |
| 219 | years.variables | 1 |
| 220 | zarylcarboxamides | 1 |
| 221 | ~0.29 | 1 |
| 222 | £1,222 | 1 |
| 223 | £118,750 | 1 |
| 224 | £1440 | 1 |
| 225 | £256.89 | 1 |
| 226 | α-maltotriosyl- | 1 |
| 227 | α1,3 | 1 |
| 228 | γ-power | 1 |
| 229 | δ-9-tetrahydrocannabinol | 1 |
| 230 | €169.75 | 1 |
| 231 | €2.82 | 1 |
| 232 | €4038 | 1 |
| 1 | ''topologically | 1 |
| 2 | -1.06mj/kg | 1 |
| 3 | -140.62 | 1 |
| 4 | -172.08 | 1 |
| 5 | -177.7 | 1 |
| 6 | -178.24 | 1 |
| 7 | -2.4±0.1 | 1 |
| 8 | -pyrimidine-4-one | 1 |
| 9 | .alcohol | 1 |
| 10 | .asthma | 1 |
| 11 | 0.0045ngmg | 1 |
| 12 | 0.045‰ | 1 |
| 13 | 0.082±0.004 | 1 |
| 14 | 0.14×10 | 1 |
| 15 | 0.64f | 1 |
| 16 | 1.04×10 | 1 |
| 17 | 1.28±2.12 | 1 |
| 18 | 1.71×10 | 1 |
| 19 | 1.97×10 | 1 |
| 20 | 10,379pounds | 1 |
| 21 | 1006.7nmol·l | 1 |
| 22 | 105cm | 1 |
| 23 | 108.40 | 1 |
| 24 | 11,428pounds | 1 |
| 25 | 112,883 | 1 |
| 26 | 116.04 | 1 |
| 27 | 125/50 | 1 |
| 28 | 127,760 | 1 |
| 29 | 13500w | 1 |
| 30 | 15.8×10 | 1 |
| 31 | 192iridium | 1 |
| 32 | 2.038 | 1 |
| 33 | 2.7x10 | 1 |
| 34 | 2.82×10 | 1 |
| 35 | 2.9x10 | 1 |
| 36 | 2007-004840-60 | 1 |
| 37 | 2020vp1 | 1 |
| 38 | 23.22±0.7m | 1 |
| 39 | 299.89ngkg | 1 |
| 40 | 2α-hydroxyl-3β-angeloylcinnamolide | 1 |
| 41 | 3-nitrobenzonitrile | 1 |
| 42 | 3.370 | 1 |
| 43 | 3.4051 | 1 |
| 44 | 3.56×10 | 1 |
| 45 | 3.8x10 | 1 |
| 46 | 36.5μmol·l | 1 |
| 47 | 4.36×10 | 1 |
| 48 | 4.69×10 | 1 |
| 49 | 4773 | 1 |
| 50 | 5.1162 | 1 |
| 51 | 5.176 | 1 |
| 52 | 5.2gy | 1 |
| 53 | 50-59years | 1 |
| 54 | 51.70 | 1 |
| 55 | 57.52×10 | 1 |
| 56 | 6,143 | 1 |
| 57 | 6.677 | 1 |
| 58 | 6.6x10 | 1 |
| 59 | 60/60/60 | 1 |
| 60 | 65.59 | 1 |
| 61 | 7.028 | 1 |
| 62 | 77.29 | 1 |
| 63 | 78.24 | 1 |
| 64 | 8-symptom | 1 |
| 65 | 8.13×10 | 1 |
| 66 | 80.96 | 1 |
| 67 | 81.33 | 1 |
| 68 | 82.47 | 1 |
| 69 | 85.31 | 1 |
| 70 | 87.37 | 1 |
| 71 | 87.41 | 1 |
| 72 | 87.62 | 1 |
| 73 | 88.48 | 1 |
| 74 | 9.11×10 | 1 |
| 75 | 9.3gy | 1 |
| 76 | a-1000 | 2 |
| 77 | action-scripts | 1 |
| 78 | air-bronchiologram | 1 |
| 79 | antiferromagnetically | 5 |
| 80 | baroceptor | 1 |
| 81 | bi-univocally | 1 |
| 82 | bronchorrhoea | 3 |
| 83 | bv-were | 1 |
| 84 | c44 | 3 |
| 85 | calcitonin-gene | 2 |
| 86 | causally | 202 |
| 87 | causatively | 3 |
| 88 | centrosymmetrically | 7 |
| 89 | chictr-trc-11001480 | 1 |
| 90 | circadian-rhythm | 1 |
| 91 | clonally | 12 |
| 92 | closely | 3,136 |
| 93 | co-coverage | 1 |
| 94 | coitally | 2 |
| 95 | communitaire | 1 |
| 96 | compactly | 5 |
| 97 | connected/very | 1 |
| 98 | critera | 2 |
| 99 | crumpled | 1 |
| 100 | curvilinearly | 16 |
| 101 | cvd- | 1 |
| 102 | delicately | 4 |
| 103 | determined.issys | 1 |
| 104 | determined.variables | 1 |
| 105 | digestion-absorption | 1 |
| 106 | distantly | 47 |
| 107 | dollars12.2 | 1 |
| 108 | dollars37 | 1 |
| 109 | dollars406 | 1 |
| 110 | don-resistance | 1 |
| 111 | dosexdifficulty | 1 |
| 112 | dsylipidemia | 3 |
| 113 | dysmenorrheal-relieving | 1 |
| 114 | employed/occupied | 1 |
| 115 | endohedrally | 1 |
| 116 | entropion/trichiasis | 1 |
| 117 | enzym | 1 |
| 118 | epidemiologicaly | 1 |
| 119 | exterior-interiorly | 2 |
| 120 | ferromagnetically | 4 |
| 121 | finely | 93 |
| 122 | fluidically | 1 |
| 123 | gerd-health | 1 |
| 124 | ggaactn | 1 |
| 125 | ghrelin/ghrh | 1 |
| 126 | gm1-enzyme | 2 |
| 127 | gse38942 | 1 |
| 128 | haart- | 1 |
| 129 | hemivaginas | 1 |
| 130 | hfe- | 1 |
| 131 | hyperbolically | 3 |
| 132 | hypkalemia | 1 |
| 133 | index-aigr | 1 |
| 134 | inexpressive | 1 |
| 135 | inextricably | 28 |
| 136 | integrally | 17 |
| 137 | interior-exteriorly | 5 |
| 138 | intimately | 75 |
| 139 | intricately | 25 |
| 140 | invetory | 1 |
| 141 | k=2×10 | 1 |
| 142 | li1.04ni | 1 |
| 143 | linearly | 833 |
| 144 | loosely | 67 |
| 145 | lv-fibrosis | 1 |
| 146 | manoeuvrable | 1 |
| 147 | menstrually | 25 |
| 148 | monflorite-huesca | 1 |
| 149 | monotonically | 55 |
| 150 | monotropically | 1 |
| 151 | most-strongly | 2 |
| 152 | multiplicatively | 5 |
| 153 | myo-inosiol | 1 |
| 154 | n-c3 | 1 |
| 155 | n-vanillyl-hexadecanamide | 1 |
| 156 | narrowly | 48 |
| 157 | nct00473837 | 1 |
| 158 | nitratable | 1 |
| 159 | nkrp1c | 1 |
| 160 | non-avm | 1 |
| 161 | non-biologically | 2 |
| 162 | non-bp | 3 |
| 163 | non-breed | 1 |
| 164 | non-childbirth | 1 |
| 165 | non-conflict | 3 |
| 166 | non-determinant | 1 |
| 167 | non-dmard | 3 |
| 168 | non-enzymatically | 3 |
| 169 | non-epilepsy | 1 |
| 170 | non-larynx | 1 |
| 171 | non-linearly | 17 |
| 172 | non-proportionally | 1 |
| 173 | nonlinear-linear-nonlinear | 1 |
| 174 | nonlinearly | 24 |
| 175 | nonmenstrually | 1 |
| 176 | nonsuperimposable | 1 |
| 177 | p-distance=0.007/0.068 | 1 |
| 178 | pad-symptoms | 1 |
| 179 | pathogenically | 9 |
| 180 | poly-phenols | 1 |
| 181 | polyglutamine-disease | 1 |
| 182 | possession-cult | 1 |
| 183 | possibly/probably | 1 |
| 184 | pound209 | 1 |
| 185 | pound82 | 1 |
| 186 | propkhmgr-d2 | 2 |
| 187 | pseudocentrosymmetrically | 1 |
| 188 | quadratically | 76 |
| 189 | quercetin-3-rutinoside | 1 |
| 190 | rad3 | 6 |
| 191 | raek^ | 1 |
| 192 | recordedand | 1 |
| 193 | restabilized | 1 |
| 194 | restriction-site | 1 |
| 195 | reversely | 21 |
| 196 | rhc-dha | 1 |
| 197 | rm1,664.46 | 1 |
| 198 | rm1,978.00 | 1 |
| 199 | rps2 | 1 |
| 200 | s-2- | 1 |
| 201 | stigma- | 1 |
| 202 | strictly | 611 |
| 203 | study-treatment | 2 |
| 204 | subnets | 1 |
| 205 | symbiotically | 2 |
| 206 | tag-snp | 1 |
| 207 | telediagnosis | 1 |
| 208 | temporally | 254 |
| 209 | thermocompression | 1 |
| 210 | thioredoxin-deficient | 1 |
| 211 | tightly | 387 |
| 212 | timed-artificially | 1 |
| 213 | traits-those | 1 |
| 214 | trimethoprim-sulfamethoxaxole | 1 |
| 215 | ubt-positive | 1 |
| 216 | unidirectionally | 6 |
| 217 | wm-load | 1 |
| 218 | wuschel | 2 |
| 219 | years.variables | 1 |
| 220 | zarylcarboxamides | 1 |
| 221 | ~0.29 | 1 |
| 222 | £1,222 | 1 |
| 223 | £118,750 | 1 |
| 224 | £1440 | 1 |
| 225 | £256.89 | 1 |
| 226 | α-maltotriosyl- | 1 |
| 227 | α1,3 | 1 |
| 228 | γ-power | 1 |
| 229 | δ-9-tetrahydrocannabinol | 1 |
| 230 | €169.75 | 1 |
| 231 | €2.82 | 1 |
| 232 | €4038 | 1 |
| 1 | s-2- | 1 |
| 2 | stigma- | 1 |
| 3 | cvd- | 1 |
| 4 | hfe- | 1 |
| 5 | α-maltotriosyl- | 1 |
| 6 | haart- | 1 |
| 7 | rm1,978.00 | 1 |
| 8 | a-1000 | 2 |
| 9 | 6.6x10 | 1 |
| 10 | 2.7x10 | 1 |
| 11 | 3.8x10 | 1 |
| 12 | 2.9x10 | 1 |
| 13 | 9.11×10 | 1 |
| 14 | 1.71×10 | 1 |
| 15 | 57.52×10 | 1 |
| 16 | 2.82×10 | 1 |
| 17 | k=2×10 | 1 |
| 18 | 8.13×10 | 1 |
| 19 | 1.04×10 | 1 |
| 20 | 0.14×10 | 1 |
| 21 | 4.36×10 | 1 |
| 22 | 3.56×10 | 1 |
| 23 | 1.97×10 | 1 |
| 24 | 15.8×10 | 1 |
| 25 | 4.69×10 | 1 |
| 26 | 108.40 | 1 |
| 27 | £1440 | 1 |
| 28 | 125/50 | 1 |
| 29 | £118,750 | 1 |
| 30 | 2007-004840-60 | 1 |
| 31 | 60/60/60 | 1 |
| 32 | 127,760 | 1 |
| 33 | 51.70 | 1 |
| 34 | 3.370 | 1 |
| 35 | chictr-trc-11001480 | 1 |
| 36 | -2.4±0.1 | 1 |
| 37 | 85.31 | 1 |
| 38 | 87.41 | 1 |
| 39 | 3.4051 | 1 |
| 40 | 2020vp1 | 1 |
| 41 | dollars12.2 | 1 |
| 42 | 1.28±2.12 | 1 |
| 43 | £1,222 | 1 |
| 44 | gse38942 | 1 |
| 45 | -140.62 | 1 |
| 46 | 87.62 | 1 |
| 47 | 5.1162 | 1 |
| 48 | €2.82 | 1 |
| 49 | pound82 | 1 |
| 50 | propkhmgr-d2 | 2 |
| 51 | rps2 | 1 |
| 52 | α1,3 | 1 |
| 53 | 81.33 | 1 |
| 54 | 6,143 | 1 |
| 55 | 4773 | 1 |
| 56 | 112,883 | 1 |
| 57 | n-c3 | 1 |
| 58 | rad3 | 6 |
| 59 | 116.04 | 1 |
| 60 | 0.082±0.004 | 1 |
| 61 | 78.24 | 1 |
| 62 | -178.24 | 1 |
| 63 | c44 | 3 |
| 64 | €169.75 | 1 |
| 65 | dollars406 | 1 |
| 66 | rm1,664.46 | 1 |
| 67 | 5.176 | 1 |
| 68 | 80.96 | 1 |
| 69 | -177.7 | 1 |
| 70 | 87.37 | 1 |
| 71 | nct00473837 | 1 |
| 72 | dollars37 | 1 |
| 73 | 82.47 | 1 |
| 74 | 6.677 | 1 |
| 75 | -172.08 | 1 |
| 76 | 7.028 | 1 |
| 77 | 2.038 | 1 |
| 78 | €4038 | 1 |
| 79 | 88.48 | 1 |
| 80 | p-distance=0.007/0.068 | 1 |
| 81 | pound209 | 1 |
| 82 | ~0.29 | 1 |
| 83 | 77.29 | 1 |
| 84 | 65.59 | 1 |
| 85 | £256.89 | 1 |
| 86 | raek^ | 1 |
| 87 | monflorite-huesca | 1 |
| 88 | bronchorrhoea | 3 |
| 89 | rhc-dha | 1 |
| 90 | dsylipidemia | 3 |
| 91 | hypkalemia | 1 |
| 92 | .asthma | 1 |
| 93 | critera | 2 |
| 94 | nkrp1c | 1 |
| 95 | wm-load | 1 |
| 96 | non-breed | 1 |
| 97 | employed/occupied | 1 |
| 98 | crumpled | 1 |
| 99 | restabilized | 1 |
| 100 | recordedand | 1 |
| 101 | non-dmard | 3 |
| 102 | don-resistance | 1 |
| 103 | 2α-hydroxyl-3β-angeloylcinnamolide | 1 |
| 104 | n-vanillyl-hexadecanamide | 1 |
| 105 | quercetin-3-rutinoside | 1 |
| 106 | co-coverage | 1 |
| 107 | manoeuvrable | 1 |
| 108 | nonsuperimposable | 1 |
| 109 | nitratable | 1 |
| 110 | 3-nitrobenzonitrile | 1 |
| 111 | trimethoprim-sulfamethoxaxole | 1 |
| 112 | gm1-enzyme | 2 |
| 113 | calcitonin-gene | 2 |
| 114 | -pyrimidine-4-one | 1 |
| 115 | bv-were | 1 |
| 116 | communitaire | 1 |
| 117 | polyglutamine-disease | 1 |
| 118 | traits-those | 1 |
| 119 | restriction-site | 1 |
| 120 | inexpressive | 1 |
| 121 | ubt-positive | 1 |
| 122 | 0.64f | 1 |
| 123 | -1.06mj/kg | 1 |
| 124 | 299.89ngkg | 1 |
| 125 | 0.0045ngmg | 1 |
| 126 | dysmenorrheal-relieving | 1 |
| 127 | ghrelin/ghrh | 1 |
| 128 | gerd-health | 1 |
| 129 | non-childbirth | 1 |
| 130 | li1.04ni | 1 |
| 131 | wuschel | 2 |
| 132 | .alcohol | 1 |
| 133 | myo-inosiol | 1 |
| 134 | δ-9-tetrahydrocannabinol | 1 |
| 135 | 1006.7nmol·l | 1 |
| 136 | 36.5μmol·l | 1 |
| 137 | 23.22±0.7m | 1 |
| 138 | air-bronchiologram | 1 |
| 139 | 105cm | 1 |
| 140 | circadian-rhythm | 1 |
| 141 | 8-symptom | 1 |
| 142 | 192iridium | 1 |
| 143 | non-avm | 1 |
| 144 | enzym | 1 |
| 145 | thermocompression | 1 |
| 146 | digestion-absorption | 1 |
| 147 | ggaactn | 1 |
| 148 | non-bp | 3 |
| 149 | tag-snp | 1 |
| 150 | nonlinear-linear-nonlinear | 1 |
| 151 | γ-power | 1 |
| 152 | index-aigr | 1 |
| 153 | baroceptor | 1 |
| 154 | hemivaginas | 1 |
| 155 | 11,428pounds | 1 |
| 156 | 10,379pounds | 1 |
| 157 | zarylcarboxamides | 1 |
| 158 | determined.variables | 1 |
| 159 | years.variables | 1 |
| 160 | entropion/trichiasis | 1 |
| 161 | telediagnosis | 1 |
| 162 | lv-fibrosis | 1 |
| 163 | poly-phenols | 1 |
| 164 | pad-symptoms | 1 |
| 165 | 50-59years | 1 |
| 166 | subnets | 1 |
| 167 | action-scripts | 1 |
| 168 | determined.issys | 1 |
| 169 | non-conflict | 3 |
| 170 | possession-cult | 1 |
| 171 | non-determinant | 1 |
| 172 | thioredoxin-deficient | 1 |
| 173 | study-treatment | 2 |
| 174 | 13500w | 1 |
| 175 | non-larynx | 1 |
| 176 | 5.2gy | 1 |
| 177 | 9.3gy | 1 |
| 178 | epidemiologicaly | 1 |
| 179 | possibly/probably | 1 |
| 180 | inextricably | 28 |
| 181 | finely | 93 |
| 182 | closely | 3,136 |
| 183 | loosely | 67 |
| 184 | reversely | 21 |
| 185 | delicately | 4 |
| 186 | intricately | 25 |
| 187 | intimately | 75 |
| 188 | multiplicatively | 5 |
| 189 | causatively | 3 |
| 190 | most-strongly | 2 |
| 191 | fluidically | 1 |
| 192 | non-biologically | 2 |
| 193 | ''topologically | 1 |
| 194 | hyperbolically | 3 |
| 195 | pathogenically | 9 |
| 196 | monotonically | 55 |
| 197 | monotropically | 1 |
| 198 | centrosymmetrically | 7 |
| 199 | pseudocentrosymmetrically | 1 |
| 200 | non-enzymatically | 3 |
| 201 | quadratically | 76 |
| 202 | ferromagnetically | 4 |
| 203 | antiferromagnetically | 5 |
| 204 | symbiotically | 2 |
| 205 | bi-univocally | 1 |
| 206 | timed-artificially | 1 |
| 207 | unidirectionally | 6 |
| 208 | non-proportionally | 1 |
| 209 | clonally | 12 |
| 210 | endohedrally | 1 |
| 211 | integrally | 17 |
| 212 | temporally | 254 |
| 213 | causally | 202 |
| 214 | coitally | 2 |
| 215 | menstrually | 25 |
| 216 | nonmenstrually | 1 |
| 217 | linearly | 833 |
| 218 | non-linearly | 17 |
| 219 | curvilinearly | 16 |
| 220 | nonlinearly | 24 |
| 221 | exterior-interiorly | 2 |
| 222 | interior-exteriorly | 5 |
| 223 | compactly | 5 |
| 224 | strictly | 611 |
| 225 | tightly | 387 |
| 226 | distantly | 47 |
| 227 | narrowly | 48 |
| 228 | connected/very | 1 |
| 229 | invetory | 1 |
| 230 | non-epilepsy | 1 |
| 231 | dosexdifficulty | 1 |
| 232 | 0.045‰ | 1 |